Back to results
US 2019/0240194 A1Published application
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
AssigneeThe General Hospital Corporation
InventorsDavid R. Elmaleh, Rudolph E. Tanzi, Timothy M. Shoup, Ana Gricluc
Life of this patent
Estimating the term…
Abstract
Described herein are methods of treating neuron inflammation conditions, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of cromolyn or a cromolyn derivative compound.
Claims21
A method of treating a neuron inflammation condition in a patient in need thereof comprising administering to the patient a therapeutically effective amount of at least one compound having the following formula:
- provided the compound is not cromolyn disodium,
- when the neuron inflammation condition is Alzheimer's Disease (AD).
9-13. (canceled)
Dependencies are inferred from the claim text.